John McNamara

Statistics

Publications

Citations

396

H-Index

Active since

2018

Affiliations

Roche (Switzerland)(Current)

University Hospital of Basel

The University of Texas Health Science Center at Houston

Vall d'Hebron Hospital Universitari

University of Basel

John McNamara is an author at Roche (Switzerland) specializing in ocrelizumab therapy, life sciences, and relapsing-remitting multiple sclerosis treatment.

Publications per year

2018–2020

Publications

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis

Amit Bar‐Or, Jonathan Calkwood, Cathy Chognot et al. · Neurology · 2020 · 339 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis (S36.002)

Daniela Stokmaier, Kevin Winthrop, Cathy Chognot et al. · Neurology · 2018 · 26 citations

Life Sciences, Immunology, Neurology +15

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary progressive Multiple Sclerosis

Stephen L. Hauser, Ludwig Kappos, Xavier Montalbán et al. · Multiple Sclerosis and Related Disorders · 2018 · 20 citations

Life Sciences, Neurology, Pharmacotherapy +10

Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis

Stephen L. Hauser, Ludwig Kappos, Xavier Montalbán et al. · Journal of the Neurological Sciences · 2019 · 11 citations

Life Sciences, Neurology, Pharmacotherapy +10

1–4 of 4